nodes	percent_of_prediction	percent_of_DWPC	metapath
Gentamicin—LRP2—Signaling events mediated by the Hedgehog family—PTCH2—brain cancer	0.068	0.217	CbGpPWpGaD
Gentamicin—LRP2—Signaling events mediated by the Hedgehog family—GLI2—brain cancer	0.0515	0.165	CbGpPWpGaD
Gentamicin—LRP2—Signaling events mediated by the Hedgehog family—SHH—brain cancer	0.035	0.112	CbGpPWpGaD
Gentamicin—LRP2—Signaling events mediated by the Hedgehog family—SMO—brain cancer	0.0332	0.106	CbGpPWpGaD
Gentamicin—LRP2—Signaling events mediated by the Hedgehog family—PTCH1—brain cancer	0.0332	0.106	CbGpPWpGaD
Gentamicin—Nephrotoxicity—Lomustine—brain cancer	0.0325	0.0561	CcSEcCtD
Gentamicin—Pulmonary fibrosis—Lomustine—brain cancer	0.0235	0.0406	CcSEcCtD
Gentamicin—Venous thrombosis—Carboplatin—brain cancer	0.0219	0.0378	CcSEcCtD
Gentamicin—Fluid overload—Carboplatin—brain cancer	0.019	0.0328	CcSEcCtD
Gentamicin—Nephropathy toxic—Lomustine—brain cancer	0.018	0.0311	CcSEcCtD
Gentamicin—LRP2—medulla oblongata—brain cancer	0.0164	0.151	CbGeAlD
Gentamicin—Atrophy—Hydroxyurea—brain cancer	0.0156	0.0269	CcSEcCtD
Gentamicin—LRP2—midbrain—brain cancer	0.015	0.138	CbGeAlD
Gentamicin—LRP2—spinal cord—brain cancer	0.0146	0.135	CbGeAlD
Gentamicin—Extravasation—Carboplatin—brain cancer	0.0135	0.0234	CcSEcCtD
Gentamicin—LRP2—endocrine gland—brain cancer	0.0131	0.121	CbGeAlD
Gentamicin—LRP2—head—brain cancer	0.013	0.12	CbGeAlD
Gentamicin—Nephrotoxicity—Carmustine—brain cancer	0.0129	0.0223	CcSEcCtD
Gentamicin—LRP2—central nervous system—brain cancer	0.0118	0.109	CbGeAlD
Gentamicin—LRP2—cerebellum—brain cancer	0.0116	0.107	CbGeAlD
Gentamicin—Pulmonary fibrosis—Hydroxyurea—brain cancer	0.0115	0.0199	CcSEcCtD
Gentamicin—LRP2—Vitamin B12 Metabolism—SOD2—brain cancer	0.0115	0.0367	CbGpPWpGaD
Gentamicin—Phlebitis—Carboplatin—brain cancer	0.00995	0.0172	CcSEcCtD
Gentamicin—LRP2—brain—brain cancer	0.0094	0.0867	CbGeAlD
Gentamicin—Pulmonary fibrosis—Carmustine—brain cancer	0.00933	0.0161	CcSEcCtD
Gentamicin—Pulmonary fibrosis—Temozolomide—brain cancer	0.00901	0.0156	CcSEcCtD
Gentamicin—Neurotoxicity—Etoposide—brain cancer	0.00818	0.0141	CcSEcCtD
Gentamicin—Hypomagnesaemia—Hydroxyurea—brain cancer	0.00799	0.0138	CcSEcCtD
Gentamicin—Visual disturbance—Lomustine—brain cancer	0.00791	0.0137	CcSEcCtD
Gentamicin—Lethargy—Lomustine—brain cancer	0.00765	0.0132	CcSEcCtD
Gentamicin—Pulmonary fibrosis—Etoposide—brain cancer	0.00721	0.0125	CcSEcCtD
Gentamicin—Nephropathy toxic—Carmustine—brain cancer	0.00714	0.0123	CcSEcCtD
Gentamicin—Hearing impaired—Procarbazine—brain cancer	0.00689	0.0119	CcSEcCtD
Gentamicin—LRP2—Vitamin B12 Metabolism—RELA—brain cancer	0.00664	0.0212	CbGpPWpGaD
Gentamicin—Encephalopathy—Carmustine—brain cancer	0.00639	0.011	CcSEcCtD
Gentamicin—Stomatitis—Lomustine—brain cancer	0.00563	0.00973	CcSEcCtD
Gentamicin—Nephropathy toxic—Etoposide—brain cancer	0.00552	0.00954	CcSEcCtD
Gentamicin—Deafness—Procarbazine—brain cancer	0.00532	0.00919	CcSEcCtD
Gentamicin—Vascular purpura—Procarbazine—brain cancer	0.00532	0.00919	CcSEcCtD
Gentamicin—Injection site pain—Carmustine—brain cancer	0.00502	0.00868	CcSEcCtD
Gentamicin—Visual impairment—Lomustine—brain cancer	0.005	0.00863	CcSEcCtD
Gentamicin—Purpura—Procarbazine—brain cancer	0.00494	0.00853	CcSEcCtD
Gentamicin—Lethargy—Procarbazine—brain cancer	0.00486	0.00839	CcSEcCtD
Gentamicin—Extravasation—Carmustine—brain cancer	0.0047	0.00812	CcSEcCtD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.00465	0.0149	CbGpPWpGaD
Gentamicin—Alopecia—Lomustine—brain cancer	0.00458	0.00792	CcSEcCtD
Gentamicin—Hearing impaired—Temozolomide—brain cancer	0.00416	0.00719	CcSEcCtD
Gentamicin—Eosinophilia—Procarbazine—brain cancer	0.00407	0.00704	CcSEcCtD
Gentamicin—Leukopenia—Lomustine—brain cancer	0.00404	0.00698	CcSEcCtD
Gentamicin—Numbness—Etoposide—brain cancer	0.00383	0.00661	CcSEcCtD
Gentamicin—LRP2—Disease—DTX2—brain cancer	0.00366	0.0117	CbGpPWpGaD
Gentamicin—Sensory loss—Etoposide—brain cancer	0.00366	0.00633	CcSEcCtD
Gentamicin—Extravasation—Etoposide—brain cancer	0.00364	0.00628	CcSEcCtD
Gentamicin—Thrombocytopenia—Lomustine—brain cancer	0.00361	0.00623	CcSEcCtD
Gentamicin—Neuropathy peripheral—Procarbazine—brain cancer	0.0036	0.00621	CcSEcCtD
Gentamicin—Stomatitis—Procarbazine—brain cancer	0.00357	0.00618	CcSEcCtD
Gentamicin—SLC22A6—brain—brain cancer	0.00355	0.0327	CbGeAlD
Gentamicin—Phlebitis—Carmustine—brain cancer	0.00346	0.00597	CcSEcCtD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.0034	0.0109	CbGpPWpGaD
Gentamicin—Body temperature increased—Carboplatin—brain cancer	0.00333	0.00575	CcSEcCtD
Gentamicin—Hallucination—Procarbazine—brain cancer	0.00328	0.00566	CcSEcCtD
Gentamicin—Vascular purpura—Temozolomide—brain cancer	0.00322	0.00556	CcSEcCtD
Gentamicin—Deafness—Temozolomide—brain cancer	0.00322	0.00556	CcSEcCtD
Gentamicin—Decreased appetite—Lomustine—brain cancer	0.0032	0.00553	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—OR4C12—brain cancer	0.00302	0.00964	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—OR14C36—brain cancer	0.00302	0.00964	CbGpPWpGaD
Gentamicin—Purpura—Temozolomide—brain cancer	0.00299	0.00516	CcSEcCtD
Gentamicin—Body temperature increased—Lomustine—brain cancer	0.00291	0.00503	CcSEcCtD
Gentamicin—Alopecia—Procarbazine—brain cancer	0.00291	0.00503	CcSEcCtD
Gentamicin—Neuropathy peripheral—Hydroxyurea—brain cancer	0.00278	0.00481	CcSEcCtD
Gentamicin—Stomatitis—Hydroxyurea—brain cancer	0.00277	0.00478	CcSEcCtD
Gentamicin—Hypokalaemia—Carmustine—brain cancer	0.00271	0.00468	CcSEcCtD
Gentamicin—LRP2—Disease—HES5—brain cancer	0.00269	0.0086	CbGpPWpGaD
Gentamicin—Phlebitis—Etoposide—brain cancer	0.00267	0.00462	CcSEcCtD
Gentamicin—Anaemia—Procarbazine—brain cancer	0.00265	0.00458	CcSEcCtD
Gentamicin—Muscular weakness—Carmustine—brain cancer	0.00263	0.00454	CcSEcCtD
Gentamicin—Hypokalaemia—Temozolomide—brain cancer	0.00262	0.00452	CcSEcCtD
Gentamicin—Leukopenia—Procarbazine—brain cancer	0.00257	0.00443	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—DTX2—brain cancer	0.00256	0.0082	CbGpPWpGaD
Gentamicin—Muscular weakness—Temozolomide—brain cancer	0.00254	0.00438	CcSEcCtD
Gentamicin—Hallucination—Hydroxyurea—brain cancer	0.00254	0.00438	CcSEcCtD
Gentamicin—Convulsion—Procarbazine—brain cancer	0.00248	0.00429	CcSEcCtD
Gentamicin—Hypertension—Procarbazine—brain cancer	0.00247	0.00427	CcSEcCtD
Gentamicin—Arthralgia—Procarbazine—brain cancer	0.00244	0.00422	CcSEcCtD
Gentamicin—Anaphylactoid reaction—Etoposide—brain cancer	0.00238	0.00411	CcSEcCtD
Gentamicin—Confusional state—Procarbazine—brain cancer	0.00236	0.00407	CcSEcCtD
Gentamicin—Vomiting—Lomustine—brain cancer	0.00234	0.00405	CcSEcCtD
Gentamicin—Thrombocytopenia—Procarbazine—brain cancer	0.00229	0.00396	CcSEcCtD
Gentamicin—Alopecia—Hydroxyurea—brain cancer	0.00225	0.00389	CcSEcCtD
Gentamicin—Weight decreased—Temozolomide—brain cancer	0.00225	0.00389	CcSEcCtD
Gentamicin—Neuropathy peripheral—Carmustine—brain cancer	0.00225	0.00389	CcSEcCtD
Gentamicin—Stomatitis—Carmustine—brain cancer	0.00224	0.00386	CcSEcCtD
Gentamicin—Erythema—Hydroxyurea—brain cancer	0.00222	0.00383	CcSEcCtD
Gentamicin—Nausea—Lomustine—brain cancer	0.00219	0.00378	CcSEcCtD
Gentamicin—Hypotension—Procarbazine—brain cancer	0.00219	0.00378	CcSEcCtD
Gentamicin—Neuropathy peripheral—Temozolomide—brain cancer	0.00217	0.00375	CcSEcCtD
Gentamicin—Stomatitis—Temozolomide—brain cancer	0.00216	0.00373	CcSEcCtD
Gentamicin—Musculoskeletal discomfort—Procarbazine—brain cancer	0.00213	0.00368	CcSEcCtD
Gentamicin—Paraesthesia—Procarbazine—brain cancer	0.0021	0.00363	CcSEcCtD
Gentamicin—LRP2—Metabolism—CYP2C9—brain cancer	0.00207	0.00662	CbGpPWpGaD
Gentamicin—Anaemia—Hydroxyurea—brain cancer	0.00205	0.00354	CcSEcCtD
Gentamicin—Hypoaesthesia—Carmustine—brain cancer	0.00205	0.00354	CcSEcCtD
Gentamicin—Hallucination—Carmustine—brain cancer	0.00205	0.00354	CcSEcCtD
Gentamicin—Decreased appetite—Procarbazine—brain cancer	0.00203	0.00351	CcSEcCtD
Gentamicin—Leukopenia—Hydroxyurea—brain cancer	0.00199	0.00343	CcSEcCtD
Gentamicin—Visual impairment—Carmustine—brain cancer	0.00199	0.00343	CcSEcCtD
Gentamicin—Hypoaesthesia—Temozolomide—brain cancer	0.00198	0.00342	CcSEcCtD
Gentamicin—Hallucination—Temozolomide—brain cancer	0.00198	0.00342	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—PTCH2—brain cancer	0.00194	0.00621	CbGpPWpGaD
Gentamicin—Feeling abnormal—Procarbazine—brain cancer	0.00193	0.00333	CcSEcCtD
Gentamicin—Convulsion—Hydroxyurea—brain cancer	0.00192	0.00332	CcSEcCtD
Gentamicin—Visual impairment—Temozolomide—brain cancer	0.00192	0.00331	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—HES5—brain cancer	0.00188	0.00602	CbGpPWpGaD
Gentamicin—Urticaria—Procarbazine—brain cancer	0.00186	0.00321	CcSEcCtD
Gentamicin—Tinnitus—Temozolomide—brain cancer	0.00186	0.00321	CcSEcCtD
Gentamicin—Body temperature increased—Procarbazine—brain cancer	0.00185	0.00319	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—STRADA—brain cancer	0.00183	0.00584	CbGpPWpGaD
Gentamicin—Alopecia—Carmustine—brain cancer	0.00182	0.00314	CcSEcCtD
Gentamicin—LRP2—Disease—IDH1—brain cancer	0.00181	0.00578	CbGpPWpGaD
Gentamicin—Erythema—Carmustine—brain cancer	0.00179	0.0031	CcSEcCtD
Gentamicin—Thrombocytopenia—Hydroxyurea—brain cancer	0.00177	0.00306	CcSEcCtD
Gentamicin—LRP2—Metabolism—BSG—brain cancer	0.00176	0.00563	CbGpPWpGaD
Gentamicin—Alopecia—Temozolomide—brain cancer	0.00176	0.00304	CcSEcCtD
Gentamicin—Neuropathy peripheral—Etoposide—brain cancer	0.00174	0.003	CcSEcCtD
Gentamicin—Erythema—Temozolomide—brain cancer	0.00173	0.00299	CcSEcCtD
Gentamicin—Stomatitis—Etoposide—brain cancer	0.00173	0.00299	CcSEcCtD
Gentamicin—Hypersensitivity—Procarbazine—brain cancer	0.00172	0.00298	CcSEcCtD
Gentamicin—LRP2—Disease—HEY1—brain cancer	0.00171	0.00548	CbGpPWpGaD
Gentamicin—LRP2—Disease—DLL1—brain cancer	0.00168	0.00538	CbGpPWpGaD
Gentamicin—Anaemia—Carmustine—brain cancer	0.00166	0.00286	CcSEcCtD
Gentamicin—Agranulocytosis—Etoposide—brain cancer	0.00166	0.00286	CcSEcCtD
Gentamicin—Pruritus—Procarbazine—brain cancer	0.00165	0.00286	CcSEcCtD
Gentamicin—Leukopenia—Carmustine—brain cancer	0.00161	0.00277	CcSEcCtD
Gentamicin—Anaemia—Temozolomide—brain cancer	0.0016	0.00277	CcSEcCtD
Gentamicin—Hypoaesthesia—Etoposide—brain cancer	0.00158	0.00274	CcSEcCtD
Gentamicin—Decreased appetite—Hydroxyurea—brain cancer	0.00157	0.00272	CcSEcCtD
Gentamicin—Vertigo—Temozolomide—brain cancer	0.00156	0.00269	CcSEcCtD
Gentamicin—Convulsion—Carmustine—brain cancer	0.00155	0.00268	CcSEcCtD
Gentamicin—Leukopenia—Temozolomide—brain cancer	0.00155	0.00268	CcSEcCtD
Gentamicin—Hypertension—Carmustine—brain cancer	0.00155	0.00267	CcSEcCtD
Gentamicin—Dizziness—Procarbazine—brain cancer	0.00155	0.00267	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—ABR—brain cancer	0.00153	0.00488	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—IDH1—brain cancer	0.00151	0.00484	CbGpPWpGaD
Gentamicin—Convulsion—Temozolomide—brain cancer	0.0015	0.00259	CcSEcCtD
Gentamicin—Hypertension—Temozolomide—brain cancer	0.0015	0.00258	CcSEcCtD
Gentamicin—Feeling abnormal—Hydroxyurea—brain cancer	0.00149	0.00258	CcSEcCtD
Gentamicin—Vomiting—Procarbazine—brain cancer	0.00149	0.00257	CcSEcCtD
Gentamicin—Confusional state—Carmustine—brain cancer	0.00148	0.00255	CcSEcCtD
Gentamicin—Arthralgia—Temozolomide—brain cancer	0.00148	0.00255	CcSEcCtD
Gentamicin—Rash—Procarbazine—brain cancer	0.00147	0.00255	CcSEcCtD
Gentamicin—Dermatitis—Procarbazine—brain cancer	0.00147	0.00255	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—GLI2—brain cancer	0.00147	0.00471	CbGpPWpGaD
Gentamicin—Headache—Procarbazine—brain cancer	0.00147	0.00253	CcSEcCtD
Gentamicin—Thrombocytopenia—Carmustine—brain cancer	0.00143	0.00248	CcSEcCtD
Gentamicin—Body temperature increased—Hydroxyurea—brain cancer	0.00143	0.00247	CcSEcCtD
Gentamicin—LRP2—Disease—SHH—brain cancer	0.00143	0.00457	CbGpPWpGaD
Gentamicin—LRP2—Disease—ENO2—brain cancer	0.00143	0.00457	CbGpPWpGaD
Gentamicin—Confusional state—Temozolomide—brain cancer	0.00143	0.00246	CcSEcCtD
Gentamicin—Anaphylactic shock—Temozolomide—brain cancer	0.00141	0.00244	CcSEcCtD
Gentamicin—Alopecia—Etoposide—brain cancer	0.00141	0.00243	CcSEcCtD
Gentamicin—Nausea—Procarbazine—brain cancer	0.00139	0.0024	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—GLI1—brain cancer	0.00139	0.00443	CbGpPWpGaD
Gentamicin—Thrombocytopenia—Temozolomide—brain cancer	0.00138	0.00239	CcSEcCtD
Gentamicin—Hypotension—Carmustine—brain cancer	0.00137	0.00236	CcSEcCtD
Gentamicin—Hypersensitivity—Hydroxyurea—brain cancer	0.00133	0.0023	CcSEcCtD
Gentamicin—Musculoskeletal discomfort—Carmustine—brain cancer	0.00133	0.0023	CcSEcCtD
Gentamicin—Paraesthesia—Carmustine—brain cancer	0.00131	0.00227	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—SUFU—brain cancer	0.00131	0.0042	CbGpPWpGaD
Gentamicin—Musculoskeletal discomfort—Temozolomide—brain cancer	0.00129	0.00223	CcSEcCtD
Gentamicin—Anaemia—Etoposide—brain cancer	0.00128	0.00221	CcSEcCtD
Gentamicin—Decreased appetite—Carmustine—brain cancer	0.00127	0.0022	CcSEcCtD
Gentamicin—Paraesthesia—Temozolomide—brain cancer	0.00127	0.00219	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—GFAP—brain cancer	0.00127	0.00405	CbGpPWpGaD
Gentamicin—Vertigo—Etoposide—brain cancer	0.00125	0.00215	CcSEcCtD
Gentamicin—Leukopenia—Etoposide—brain cancer	0.00124	0.00214	CcSEcCtD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	0.00123	0.00394	CbGpPWpGaD
Gentamicin—Decreased appetite—Temozolomide—brain cancer	0.00123	0.00212	CcSEcCtD
Gentamicin—Feeling abnormal—Carmustine—brain cancer	0.00121	0.00208	CcSEcCtD
Gentamicin—Convulsion—Etoposide—brain cancer	0.0012	0.00208	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—HEY1—brain cancer	0.0012	0.00384	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—ENO2—brain cancer	0.0012	0.00383	CbGpPWpGaD
Gentamicin—Hypertension—Etoposide—brain cancer	0.0012	0.00207	CcSEcCtD
Gentamicin—Dizziness—Hydroxyurea—brain cancer	0.0012	0.00207	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—DLL1—brain cancer	0.00118	0.00377	CbGpPWpGaD
Gentamicin—Feeling abnormal—Temozolomide—brain cancer	0.00117	0.00201	CcSEcCtD
Gentamicin—Body temperature increased—Carmustine—brain cancer	0.00116	0.002	CcSEcCtD
Gentamicin—Vomiting—Hydroxyurea—brain cancer	0.00115	0.00199	CcSEcCtD
Gentamicin—Rash—Hydroxyurea—brain cancer	0.00114	0.00197	CcSEcCtD
Gentamicin—Confusional state—Etoposide—brain cancer	0.00114	0.00197	CcSEcCtD
Gentamicin—Dermatitis—Hydroxyurea—brain cancer	0.00114	0.00197	CcSEcCtD
Gentamicin—Headache—Hydroxyurea—brain cancer	0.00113	0.00196	CcSEcCtD
Gentamicin—Anaphylactic shock—Etoposide—brain cancer	0.00113	0.00196	CcSEcCtD
Gentamicin—Urticaria—Temozolomide—brain cancer	0.00112	0.00194	CcSEcCtD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—S100A10—brain cancer	0.00112	0.00358	CbGpPWpGaD
Gentamicin—Body temperature increased—Temozolomide—brain cancer	0.00112	0.00193	CcSEcCtD
Gentamicin—Thrombocytopenia—Etoposide—brain cancer	0.00111	0.00191	CcSEcCtD
Gentamicin—Hypersensitivity—Carmustine—brain cancer	0.00108	0.00186	CcSEcCtD
Gentamicin—Nausea—Hydroxyurea—brain cancer	0.00108	0.00186	CcSEcCtD
Gentamicin—Hypotension—Etoposide—brain cancer	0.00106	0.00183	CcSEcCtD
Gentamicin—Hypersensitivity—Temozolomide—brain cancer	0.00104	0.0018	CcSEcCtD
Gentamicin—LRP2—Disease—VAV1—brain cancer	0.00103	0.0033	CbGpPWpGaD
Gentamicin—Paraesthesia—Etoposide—brain cancer	0.00102	0.00176	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—SHH—brain cancer	0.001	0.0032	CbGpPWpGaD
Gentamicin—Pruritus—Temozolomide—brain cancer	0.001	0.00173	CcSEcCtD
Gentamicin—Decreased appetite—Etoposide—brain cancer	0.000984	0.0017	CcSEcCtD
Gentamicin—Dizziness—Carmustine—brain cancer	0.000968	0.00167	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—TRPC6—brain cancer	0.000966	0.00309	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—SMO—brain cancer	0.000949	0.00304	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—PTCH1—brain cancer	0.000949	0.00304	CbGpPWpGaD
Gentamicin—Dizziness—Temozolomide—brain cancer	0.000935	0.00162	CcSEcCtD
Gentamicin—Feeling abnormal—Etoposide—brain cancer	0.000933	0.00161	CcSEcCtD
Gentamicin—Vomiting—Carmustine—brain cancer	0.00093	0.00161	CcSEcCtD
Gentamicin—Rash—Carmustine—brain cancer	0.000923	0.00159	CcSEcCtD
Gentamicin—Dermatitis—Carmustine—brain cancer	0.000922	0.00159	CcSEcCtD
Gentamicin—Headache—Carmustine—brain cancer	0.000917	0.00158	CcSEcCtD
Gentamicin—Vomiting—Temozolomide—brain cancer	0.000899	0.00155	CcSEcCtD
Gentamicin—Urticaria—Etoposide—brain cancer	0.000899	0.00155	CcSEcCtD
Gentamicin—Body temperature increased—Etoposide—brain cancer	0.000895	0.00155	CcSEcCtD
Gentamicin—Rash—Temozolomide—brain cancer	0.000892	0.00154	CcSEcCtD
Gentamicin—Dermatitis—Temozolomide—brain cancer	0.000891	0.00154	CcSEcCtD
Gentamicin—LRP2—Disease—HES1—brain cancer	0.000889	0.00284	CbGpPWpGaD
Gentamicin—Headache—Temozolomide—brain cancer	0.000886	0.00153	CcSEcCtD
Gentamicin—Nausea—Carmustine—brain cancer	0.000869	0.0015	CcSEcCtD
Gentamicin—LRP2—Disease—PDGFRA—brain cancer	0.000846	0.0027	CbGpPWpGaD
Gentamicin—Nausea—Temozolomide—brain cancer	0.00084	0.00145	CcSEcCtD
Gentamicin—Hypersensitivity—Etoposide—brain cancer	0.000834	0.00144	CcSEcCtD
Gentamicin—Pruritus—Etoposide—brain cancer	0.000801	0.00138	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—NOTCH2—brain cancer	0.000759	0.00243	CbGpPWpGaD
Gentamicin—Dizziness—Etoposide—brain cancer	0.000748	0.00129	CcSEcCtD
Gentamicin—LRP2—Disease—IRS2—brain cancer	0.000743	0.00237	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—VAV1—brain cancer	0.000723	0.00231	CbGpPWpGaD
Gentamicin—Vomiting—Etoposide—brain cancer	0.00072	0.00124	CcSEcCtD
Gentamicin—Rash—Etoposide—brain cancer	0.000714	0.00123	CcSEcCtD
Gentamicin—Dermatitis—Etoposide—brain cancer	0.000713	0.00123	CcSEcCtD
Gentamicin—Headache—Etoposide—brain cancer	0.000709	0.00122	CcSEcCtD
Gentamicin—Nausea—Etoposide—brain cancer	0.000672	0.00116	CcSEcCtD
Gentamicin—LRP2—Disease—APC—brain cancer	0.000656	0.0021	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—HES1—brain cancer	0.000622	0.00199	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—PDGFRA—brain cancer	0.000592	0.00189	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—SPP1—brain cancer	0.000575	0.00184	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—PIK3CG—brain cancer	0.000549	0.00176	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—IRS2—brain cancer	0.00052	0.00166	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—TRPC6—brain cancer	0.000518	0.00166	CbGpPWpGaD
Gentamicin—LRP2—Disease—ERBB2—brain cancer	0.000509	0.00163	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—APC—brain cancer	0.000459	0.00147	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—PIK3CG—brain cancer	0.000459	0.00147	CbGpPWpGaD
Gentamicin—LRP2—Disease—CTNNB1—brain cancer	0.000446	0.00142	CbGpPWpGaD
Gentamicin—LRP2—Disease—STAT3—brain cancer	0.000388	0.00124	CbGpPWpGaD
Gentamicin—LRP2—Disease—MYC—brain cancer	0.000361	0.00115	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—RELA—brain cancer	0.000359	0.00115	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—ERBB2—brain cancer	0.000357	0.00114	CbGpPWpGaD
Gentamicin—LRP2—Disease—EGFR—brain cancer	0.000353	0.00113	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—IL2—brain cancer	0.000323	0.00103	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—CCND1—brain cancer	0.000315	0.00101	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—CTNNB1—brain cancer	0.000312	0.000998	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—VEGFA—brain cancer	0.000275	0.000878	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—STAT3—brain cancer	0.000272	0.00087	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—MYC—brain cancer	0.000253	0.000808	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—EGFR—brain cancer	0.000247	0.00079	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—TP53—brain cancer	0.000208	0.000664	CbGpPWpGaD
